Preventing muscle loss for movement longevity

Media Release

15 June 2020

Healthy muscles are related to strong quality-of-life measures, and support independence throughout the ageing process.1

Normal, healthy ageing in humans is accompanied by decreases in muscle function, motor performance and other functions.2

When otherwise normal changes have become severe, large losses of muscle mass are associated with poor health outcomes.3

As such, prevention of muscle mass loss is a necessary part of support for healthy ageing.

Loss of muscle mass starts early, beginning as early as age 30 and becoming more evident when patients are over 50 years of age.2

So too, should preventative efforts start early. Health professionals can assist patients with symptoms of muscular decline, and screen for more severe causes.

Guild Learning and Development, in partnership with Metagenics, has developed a new online course to educate pharmacists about maintaining muscle health titled The muscle health continuum:  preventing muscle mass loss for movement longevity.

This course educates pharmacists on the importance of maintaining lifelong muscle health, preventing progressive muscle decline, and managing muscular decline as it occurs.

This activity has been accredited for one hour of Group 1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to one hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities.

To enrol in this course please visit guilded.guild.org.au.

Please contact Guild Learning and Development on 1800 049 056 or email learninganddevelopment@guild.org.au for more information.

References:

  1. Wolfe R. The underappreciated role of muscle in health and disease. The American Journal of Clinical Nutrition. 2006; 84(3): p. 475-482.
  2. Cruz-Jentoft A, Sayer A. Sarcopenia. The Lancet. 2019; 393(10191): p. 2636-2646
  3. Prado CM, Purcell SA, Alish C, et al. Implications of low muscle mass across the continuum of care: a narrative review. Ann Med. 2018;50(8): p. 675–693.

Text by: The Pharmacy Guild of Australia

Must Read

New regional roadmaps for prioritising antimicrobial resistance

0
A new publication by the International Pharmaceutical Federation (FIP) identifies priority actions pharmacists should take to minimise antimicrobial resistance (AMR). The publication presents six...